In fact, genetic deficiency of IL17RA or IL17F is associated with chronic mucocutaneous candidiasis (122) and secukinumab -induced IL17F inhibition results in increased incidence of Candida spp. Here, IL17F is linked to chronic mucocutaneous candidiasis.